Based on the Neogen Corporation stock forecast from 2 analysts, the average analyst target price for Neogen Corporation is USD 16.38 over the next 12 months. Neogen Corporation’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Neogen Corporation is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, Neogen Corporation’s stock price was USD 12.22. Neogen Corporation’s stock price has changed by +0.74% over the past week, -18.42% over the past month and -40.77% over the last year.
No recent analyst target price found for Neogen Corporation
No recent average analyst rating found for Neogen Corporation
Company Overview Neogen Corporation
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan. Read Less
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offe...Read More
Frequently Asked Questions About Neogen Corporation (NEOG) Stock
Based on ratings from 2 analysts Neogen Corporation's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on NEOG's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for NEOG is USD 16.38 over the next 12 months. The maximum analyst target price is USD 17.5 while the minimum anlayst target price is USD 15.
NEOG stock's Price/Earning ratio is 816.50.
Our analysis grades NEOG stock's Price / Earning ratio at F. This means that NEOG stock's Price/Earning ratio is above 95% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this NEOG may be a overvalued for its sector.
The last closing price of NEOG's stock was USD 12.22.
The most recent market capitalization for NEOG is USD 2.75B.
Based on targets from 2 analysts, the average taret price for NEOG is projected at USD 16.38 over the next 12 months.
This means that NEOG's stock price may go up by +34.00% over the next 12 months.
We can't find any ETFs which contains Neogen Corporation's stock.
As per our most recent records Neogen Corporation has 2,917 Employees.
Neogen Corporation's registered address is 620 Lesher Place, Lansing, MI, United States, 48912-1595.
You can get more information about it from Neogen Corporation's website at https://www.neogen.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Neogen Corporation (NEOG) Stock
Based on ratings from 2 analysts Neogen Corporation's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 1 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on NEOG's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for NEOG is USD 16.38 over the next 12 months. The maximum analyst target price is USD 17.5 while the minimum anlayst target price is USD 15.
NEOG stock's Price/Earning ratio is 816.50.
Our analysis grades NEOG stock's Price / Earning ratio at F. This means that NEOG stock's Price/Earning ratio is above 95% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this NEOG may be a overvalued for its sector.
The last closing price of NEOG's stock was USD 12.22.
The most recent market capitalization for NEOG is USD 2.75B.
Based on targets from 2 analysts, the average taret price for NEOG is projected at USD 16.38 over the next 12 months.
This means that NEOG's stock price may go up by +34.00% over the next 12 months.
We can't find any ETFs which contains Neogen Corporation's stock.
As per our most recent records Neogen Corporation has 2,917 Employees.
Neogen Corporation's registered address is 620 Lesher Place, Lansing, MI, United States, 48912-1595.
You can get more information about it from Neogen Corporation's website at https://www.neogen.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NEOG !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
